COVID-19: Spanish biotech is looking for partners to develop novel immunotherapies against COVID19 based on Chimeric Virus Like Particles in Eureka programs, H2020 and similar
A Spanish SME is looking for partners who could support the screening and selection of COVID19 antigens to develop prototypes against COVID19. The company has a proven platform technology of chimeric virus like particles that would display selected antigens to elicit strong immune responses in humans. The project has 3 main phases: design of prototypes, screening & production and immunogenic. Companies, research institution or universities experienced in research health are sought (Eureka).